A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2007
12/27/2007	US20070298065 2-Cyclopentyl-4-(4-phenoxyphenyl)thiazole-5-carboxamide; amidation; oxidation; cyclization;
12/27/2007	US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos)
12/27/2007	US20070298045 Method and vaccine for non-genetically engineered atavism growth enhancement
12/27/2007	US20070298041 Ligands That Enhance Endogenous Compounds
12/27/2007	US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007	US20070298033 Human Anti-Idiotypic Antibody Fragments that Mimic Her-2/Neu
12/27/2007	US20070298022 Identification of Phospholipase A2 as Target in Cancer Treatment, with Special Emphasis on Colorectal Cancer and Its Mechanism of Action
12/27/2007	US20070298014 Probiotic therapy of neonatal meningitis and method of using E. coli virulence determinants
12/27/2007	US20070298011 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/27/2007	US20070297989 Novel anti-inflammatory androstane derivatives
12/27/2007	US20070297984 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses
12/27/2007	US20070297976 Metal Ion-Labeled Bis-Aminoethanethiol-Targeting Ligand Conjugates, Compositions, and Methods for Tissue-Specific Imaging
12/27/2007	DE4240430B4 Stabilisiertes pharmazeutisches Mittel, enthaltend einen HMG-CoA-Reduktase-Inhibitor Wirkstoff A stabilized pharmaceutical composition comprising an HMG-CoA reductase inhibitor active agent
12/27/2007	DE202007013655U1 Verwendung von Hypericum perforatum und/oder Conium maculatum und/oder Arnica montana in Kombination zur Herstellung eines Arzneimittels zur therapeutischen Behandlung des spinalen Querschnittssyndroms Use of Hypericum perforatum and / or Conium maculatum and / or Arnica montana in combination for the manufacture of a medicament for therapeutic treatment of the spinal cross-sectional syndrome
12/27/2007	CA2655895A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007	CA2655788A1 Skin external preparation containing triterpenic acid
12/27/2007	CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/26/2007	EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors
12/26/2007	EP1870419A2 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/26/2007	EP1870404A1 Agent for treatment of hematopoietic tumor
12/26/2007	EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007	EP1870115A1 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
12/26/2007	EP1870101A1 Aerosol formulation for inhalation containing an anticholinergic agent
12/26/2007	EP1870100A1 Pharmaceutical composition for oral application comprising ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate mesylate
12/26/2007	EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes
12/26/2007	EP1868633A2 Compositions and methods for the inhibition of dishevelled proteins
12/26/2007	EP1868624A2 Compositions comprising probiotic and sweetener components
12/26/2007	EP1868621A1 Inorganic materials for hemostatic modulation and therapeutic wound healing
12/26/2007	EP1503797B1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
12/26/2007	EP1491531B1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
12/26/2007	EP1478770B1 Screening method for orthopoxvirus antivirals
12/26/2007	EP1441714B1 Combinations comprising a selective cyclooxygenase-2 inhibitor
12/26/2007	EP1333810B1 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
12/26/2007	EP1330999B1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative
12/26/2007	EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/26/2007	EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/26/2007	EP1235596B1 Use of lytic toxins and toxin conjugates
12/26/2007	EP1233769B1 Imidazole derivatives
12/26/2007	EP0996710B1 Component of bromelain
12/26/2007	EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
12/26/2007	EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy
12/26/2007	CN101094851A Novel compound having lipase inhibitory activity
12/26/2007	CN101094678A Blood cholesterol reducing oral composition
12/26/2007	CN101092457A Human source Fab antibody for anti recombined alkalescent fibroblast growth factor and application
12/26/2007	CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/26/2007	CN101092442A Steroid compounds having contraceptive and anti-osteoporosis activity
12/26/2007	CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/26/2007	CN101092394A Method for preparing Meixianduoxin
12/26/2007	CN101092388A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
12/26/2007	CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007	CN101091713A Tripterine capsule in use for preventing and treating disease of nerve damage, preparation method and usage
12/26/2007	CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease
12/26/2007	CN101091570A Health care food of soft capsule of hickory nut oil and preparation method
12/26/2007	CN101091569A Health care food of oral liquid of hickory nut oil and preparation method
12/26/2007	CN101091505A Relieving summer-heat and cooling down tea, and preparation technique
12/26/2007	CN100357734C Quality control method for children hyperkinetic symptom therapeutic traditional Chinese medicine formulation
12/26/2007	CN100357323C Cell shifting related protein and its coding gene and application
12/26/2007	CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
12/26/2007	CN100357287C Antineoplastic cocoa extracts and methods for making and using the same
12/26/2007	CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
12/26/2007	CN100357270C D-proline derivative
12/26/2007	CN100357267C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
12/26/2007	CN100356982C Adeno-associated virus vector preparation and medicinal composition containing it and its use
12/26/2007	CN100356966C Heatstroke treating medicine
12/26/2007	CN100356928C Use of red yeast in preparing anti-inflammatory medicine
12/26/2007	CN100356917C Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes
12/26/2007	CN100356916C Pharmaceutical compositions
12/26/2007	CN100356853C Antimicrobial agent
12/25/2007	US7312373 Nonhuman model animal lacking the ability to control lymphocyte migration
12/25/2007	US7312360 Substituted hydroxyethylamines
12/25/2007	US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007	US7312344 Dimeric isoflavones
12/25/2007	US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof
12/25/2007	US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007	US7312317 P2Y4 antibodies
12/25/2007	US7312304 Somatostatin agonists
12/25/2007	US7312237 Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
12/25/2007	US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007	US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders
12/25/2007	US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007	US7312224 Pyrimidine derivatives
12/25/2007	US7312219 Antidiabetic agents
12/25/2007	US7312216 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent
12/25/2007	US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007	US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007	US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics
12/25/2007	US7312196 Formulations for amylin agonist peptides
12/25/2007	US7312188 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP)
12/25/2007	US7311919 Agents for treating osteoporosis and inhibiting osteoclast formation
12/21/2007	WO2007146178A1 A method of reducing amyloid-beta peptide levels using a bisdioxopiperazine
12/21/2007	WO2007145356A1 α-GLUCOSIDASE INHIBITOR, INHIBITOR FOR BLOOD GLUCOSE LEVEL ELEVATION AND FUNCTIONAL FOOD CONTAINING TRICAFFEOYLALDARIC ACID AND METHOD FOR PRODUCING TRICAFFEOYLALDARIC ACID
12/21/2007	WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue
12/21/2007	WO2007145253A1 NF-ϰB ACTIVATION INHIBITOR
12/21/2007	WO2007145239A1 Anti-fatigue agent containing amino acid composition
12/21/2007	WO2007145227A1 Hematopoietic stem cell proliferation promoter
12/21/2007	WO2007144985A1 Use of rpn2 gene expression inhibitor
12/21/2007	WO2007144943A1 Composition for enhancing immune function
12/21/2007	WO2007144358A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration
12/21/2007	WO2007143897A1 A compound with special property, compositon comprising the compound and its preparation and uses
12/21/2007	CA2657951A1 Agents for promoting the growth of hematopoietic stem cells

1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 1564